Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yafen Li

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
World Journal of Surgical Oncology|February 22, 2019
Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial eraYue Liang, Xiaosong Chen, Yiwei Tong, et al.
European Journal of Medical Research|March 21, 2023
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemiaShuangshuang Fan, Tian Wang, Fengtao You, et al.
BMC Cancer|October 31, 2015
Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patientsXiaosong Chen, Siji Zhu, Xiaochun Fei, et al.
Oncotarget|March 17, 2018
The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysisShuangshuang Lu, Jiayi Wu, Yan Fang, et al.
Oncotarget|May 5, 2016
Prognostic and predictive value of Ki-67 in triple-negative breast cancerWei Wang, Jiayi Wu, Peifeng Zhang, et al.
BMC Cancer|August 21, 2013
Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancerXiaosong Chen, Long Sun, Yan Mao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 5, 2018
A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence scoreFeilin Qu, Xiaosong Chen, Xiaochun Fei, et al.
Cancer Management and Research|May 23, 2019
A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumabJin Hong, Xiaosong Chen, Weiqi Gao, et al.
European Journal of Pharmacology|February 7, 2026
Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation StudyYafen Li, Hongyi Tan, Jinlian Xie, et al.
Frontiers in Immunology|May 18, 2026
Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expressionShuai Li, Jiahui Huang, Yifei Zhu, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
World Journal of Surgical Oncology|February 22, 2019
Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial eraYue Liang, Xiaosong Chen, Yiwei Tong, et al.
European Journal of Medical Research|March 21, 2023
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemiaShuangshuang Fan, Tian Wang, Fengtao You, et al.
BMC Cancer|October 31, 2015
Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patientsXiaosong Chen, Siji Zhu, Xiaochun Fei, et al.
Oncotarget|March 17, 2018
The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysisShuangshuang Lu, Jiayi Wu, Yan Fang, et al.
Oncotarget|May 5, 2016
Prognostic and predictive value of Ki-67 in triple-negative breast cancerWei Wang, Jiayi Wu, Peifeng Zhang, et al.
BMC Cancer|August 21, 2013
Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancerXiaosong Chen, Long Sun, Yan Mao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 5, 2018
A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence scoreFeilin Qu, Xiaosong Chen, Xiaochun Fei, et al.
Cancer Management and Research|May 23, 2019
A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumabJin Hong, Xiaosong Chen, Weiqi Gao, et al.
European Journal of Pharmacology|February 7, 2026
Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation StudyYafen Li, Hongyi Tan, Jinlian Xie, et al.
Frontiers in Immunology|May 18, 2026
Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expressionShuai Li, Jiahui Huang, Yifei Zhu, et al.
Pageof 11